These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

277 related articles for article (PubMed ID: 20035078)

  • 21. Increased serum matrix metalloproteinase-9 in neuromyelitis optica: implication of disruption of blood-brain barrier.
    Hosokawa T; Nakajima H; Doi Y; Sugino M; Kimura F; Hanafusa T; Takahashi T
    J Neuroimmunol; 2011 Jul; 236(1-2):81-6. PubMed ID: 21621856
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Matrix metalloproteinase-2 and metalloproteinase-9 activities are associated with blood-brain barrier dysfunction in an animal model of severe sepsis.
    Dal-Pizzol F; Rojas HA; dos Santos EM; Vuolo F; Constantino L; Feier G; Pasquali M; Comim CM; Petronilho F; Gelain DP; Quevedo J; Moreira JC; Ritter C
    Mol Neurobiol; 2013 Aug; 48(1):62-70. PubMed ID: 23479197
    [TBL] [Abstract][Full Text] [Related]  

  • 23. NADPH oxidase plays a central role in blood-brain barrier damage in experimental stroke.
    Kahles T; Luedike P; Endres M; Galla HJ; Steinmetz H; Busse R; Neumann-Haefelin T; Brandes RP
    Stroke; 2007 Nov; 38(11):3000-6. PubMed ID: 17916764
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Disruption of the blood-brain barrier after generalized tonic-clonic seizures correlates with cerebrospinal fluid MMP-9 levels.
    Li YJ; Wang ZH; Zhang B; Zhe X; Wang MJ; Shi ST; Bai J; Lin T; Guo CJ; Zhang SJ; Kong XL; Zuo X; Zhao H
    J Neuroinflammation; 2013 Jul; 10():80. PubMed ID: 23829879
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Matrix metalloproteinases during and outside of migraine attacks without aura.
    Ashina M; Tvedskov JF; Lipka K; Bilello J; Penkowa M; Olesen J
    Cephalalgia; 2010 Mar; 30(3):303-10. PubMed ID: 19614693
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Blood-Brain Barrier Permeability and Kinetics of Inflammatory Markers in Acute Stroke Patients Treated With Thrombectomy.
    Bani-Sadr A; Mechtouff L; De Bourguignon C; Mauffrey A; Boutelier T; Cho TH; Cappucci M; Ameli R; Hermier M; Derex L; Nighoghossian N; Berthezene Y
    Neurology; 2023 Aug; 101(5):e502-e511. PubMed ID: 37290975
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Matrix Metalloproteinase-12 Induces Blood-Brain Barrier Damage After Focal Cerebral Ischemia.
    Chelluboina B; Klopfenstein JD; Pinson DM; Wang DZ; Vemuganti R; Veeravalli KK
    Stroke; 2015 Dec; 46(12):3523-31. PubMed ID: 26534974
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Early time course of FLAIR signal intensity differs between acute ischemic stroke patients with and without hyperintense acute reperfusion marker.
    Ostwaldt AC; Rozanski M; Schmidt WU; Nolte CH; Hotter B; Jungehuelsing GJ; Villringer K; Fiebach JB
    Cerebrovasc Dis; 2014; 37(2):141-6. PubMed ID: 24481492
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Serum matrix metalloproteinase-9 and tissue inhibitor of metalloproteinase-1 levels in patients with tick-borne encephalitis.
    Palus M; Zampachová E; Elsterová J; Růžek D
    J Infect; 2014 Feb; 68(2):165-9. PubMed ID: 24091083
    [TBL] [Abstract][Full Text] [Related]  

  • 30. A matrix metalloproteinase protein array reveals a strong relation between MMP-9 and MMP-13 with diffusion-weighted image lesion increase in human stroke.
    Rosell A; Alvarez-Sabín J; Arenillas JF; Rovira A; Delgado P; Fernández-Cadenas I; Penalba A; Molina CA; Montaner J
    Stroke; 2005 Jul; 36(7):1415-20. PubMed ID: 15947272
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Carcinoembryonic antigen-related cell adhesion molecule 1 inhibits MMP-9-mediated blood-brain-barrier breakdown in a mouse model for ischemic stroke.
    Ludewig P; Sedlacik J; Gelderblom M; Bernreuther C; Korkusuz Y; Wagener C; Gerloff C; Fiehler J; Magnus T; Horst AK
    Circ Res; 2013 Sep; 113(8):1013-22. PubMed ID: 23780386
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Matrix metalloproteinase expression increases after cerebral focal ischemia in rats: inhibition of matrix metalloproteinase-9 reduces infarct size.
    Romanic AM; White RF; Arleth AJ; Ohlstein EH; Barone FC
    Stroke; 1998 May; 29(5):1020-30. PubMed ID: 9596253
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Transient brain hypothermia reduces the reperfusion injury of delayed tissue plasminogen activator and extends its therapeutic time window in a focal embolic stroke model.
    Zarisfi M; Allahtavakoli F; Hassanipour M; Khaksari M; Rezazadeh H; Allahtavakoli M; Taghavi MM
    Brain Res Bull; 2017 Sep; 134():85-90. PubMed ID: 28710023
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Association of molecular markers with perihematomal edema and clinical outcome in intracerebral hemorrhage.
    Li N; Liu YF; Ma L; Worthmann H; Wang YL; Wang YJ; Gao YP; Raab P; Dengler R; Weissenborn K; Zhao XQ
    Stroke; 2013 Mar; 44(3):658-63. PubMed ID: 23391772
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Cyclooxygenase inhibition limits blood-brain barrier disruption following intracerebral injection of tumor necrosis factor-alpha in the rat.
    Candelario-Jalil E; Taheri S; Yang Y; Sood R; Grossetete M; Estrada EY; Fiebich BL; Rosenberg GA
    J Pharmacol Exp Ther; 2007 Nov; 323(2):488-98. PubMed ID: 17704356
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Matrix metalloproteinase-9 as a marker for acute ischemic stroke: a systematic review.
    Ramos-Fernandez M; Bellolio MF; Stead LG
    J Stroke Cerebrovasc Dis; 2011; 20(1):47-54. PubMed ID: 21044610
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Loss of flow induces leukocyte-mediated MMP/TIMP imbalance in dynamic in vitro blood-brain barrier model: role of pro-inflammatory cytokines.
    Krizanac-Bengez L; Hossain M; Fazio V; Mayberg M; Janigro D
    Am J Physiol Cell Physiol; 2006 Oct; 291(4):C740-9. PubMed ID: 16707552
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Evaluation of matrix metalloproteinase, myeloperoxidase, and oxidative damage in mesenteric ischemia-reperfusion injury.
    Kocael A; Inal BB; Guntas G; Kelten C; Inal H; Topac HI; Kocael P; Simsek O; Karaca G; Salihoglu Z; Uzun H
    Hum Exp Toxicol; 2016 Aug; 35(8):851-60. PubMed ID: 26429927
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Early beneficial effect of matrix metalloproteinase inhibition on blood-brain barrier permeability as measured by magnetic resonance imaging countered by impaired long-term recovery after stroke in rat brain.
    Sood RR; Taheri S; Candelario-Jalil E; Estrada EY; Rosenberg GA
    J Cereb Blood Flow Metab; 2008 Feb; 28(2):431-8. PubMed ID: 17700631
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Matrix metalloproteinase expression is related to hemorrhagic transformation after cardioembolic stroke.
    Montaner J; Alvarez-Sabín J; Molina CA; Anglés A; Abilleira S; Arenillas J; Monasterio J
    Stroke; 2001 Dec; 32(12):2762-7. PubMed ID: 11739970
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.